Technical Analysis for PTCT - PTC Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Spinning Top | Other | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | -1.83% | |
Crossed Above 20 DMA | Bullish | -1.83% | |
Pocket Pivot | Bullish Swing Setup | -1.83% | |
Inside Day | Range Contraction | -1.83% | |
Fell Below 20 DMA | Bearish | 0.42% | |
Multiple of Ten Bearish | Other | 0.42% | |
Wide Bands | Range Expansion | 0.42% | |
Gapped Down | Weakness | 0.42% |
Alert | Time |
---|---|
Down 3% | about 20 hours ago |
Fell Below Previous Day's Low | about 20 hours ago |
Down 2 % | about 20 hours ago |
Fell Below 20 DMA | about 21 hours ago |
20 DMA Support | about 21 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 04/25/2024
PTC Therapeutics, Inc. Description
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Infectious Diseases Neurological Disorders Gene Expression Dystrophy Cystic Fibrosis Muscular Dystrophy Neurodegenerative Disorders Transcription Spinal Muscular Atrophy Genzyme Neuromuscular Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 59.75 |
52 Week Low | 17.53 |
Average Volume | 1,005,129 |
200-Day Moving Average | 30.76 |
50-Day Moving Average | 27.81 |
20-Day Moving Average | 29.27 |
10-Day Moving Average | 30.47 |
Average True Range | 1.62 |
RSI (14) | 50.50 |
ADX | 29.39 |
+DI | 19.00 |
-DI | 15.67 |
Chandelier Exit (Long, 3 ATRs) | 28.04 |
Chandelier Exit (Short, 3 ATRs) | 29.99 |
Upper Bollinger Bands | 33.15 |
Lower Bollinger Band | 25.39 |
Percent B (%b) | 0.47 |
BandWidth | 26.52 |
MACD Line | 0.82 |
MACD Signal Line | 0.99 |
MACD Histogram | -0.1734 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 30.92 | ||||
Resistance 3 (R3) | 30.98 | 30.41 | 30.60 | ||
Resistance 2 (R2) | 30.41 | 29.92 | 30.38 | 30.49 | |
Resistance 1 (R1) | 29.71 | 29.63 | 29.43 | 29.65 | 30.39 |
Pivot Point | 29.14 | 29.14 | 29.00 | 29.11 | 29.14 |
Support 1 (S1) | 28.44 | 28.65 | 28.16 | 28.38 | 27.63 |
Support 2 (S2) | 27.87 | 28.36 | 27.84 | 27.53 | |
Support 3 (S3) | 27.17 | 27.87 | 27.42 | ||
Support 4 (S4) | 27.11 |